Skip to main content
PCI Biotech Holding logo

PCI Biotech Holding — Investor Relations & Filings

Ticker · PCIB ISIN · NO0010405640 LEI · 5967007LIEEXZXFIGG77 OL Manufacturing
Open in API
Filings indexed 752 across all filing types
Latest filing 2014-04-22 Remuneration Information
Country NO Norway
Listing OL PCIB

About PCI Biotech Holding

https://www.pcibiotech.no/

PCI Biotech Holding is a biopharmaceutical company developing therapeutic products based on its proprietary Photochemical Internalization (PCI) technology. This platform is a drug and nucleic acid delivery system designed to enhance the intracellular delivery of therapeutic molecules. The company's development programs are focused on applications in immunotherapy, dermatology, and bioprocessing for the manufacturing of viral vectors. A primary therapeutic area for the technology is cancer, where it aims to improve the efficacy of novel and existing treatments.

Recent filings

Filing Released Lang Actions
PCI Biotech: Innkalling til ordinær generalforsamling 2014
Remuneration Information Classification · 99% confidence The document title is "Styrets erklæring om fastsettelse av lønn og annen godtgjørelse for ledende ansatte" (Board's statement on determination of salary and other remuneration for executive employees). The text explicitly states it is prepared by the board in accordance with Norwegian public limited liability companies act (§ 6-16a) and presented to the general meeting (§ 5-6 third paragraph). This content directly addresses executive compensation, bonuses, stock options, and pension schemes, which falls under the definition of remuneration information for directors and top executives. This aligns perfectly with the 'Remuneration Information' category, coded as DEF 14A, even though the document is Norwegian and not a US SEC DEF 14A filing, the *content* matches the definition provided for DEF 14A (Report detailing compensation for top executives and directors).
2014-04-22 Norwegian
PCI Biotech: Notice of Annual General Meeting 2014
AGM Information Classification · 99% confidence The document is titled "INNKALLING TIL ORDINÆR GENERALFORSAMLING 2014" (Notice of Annual General Meeting 2014) and details the agenda, including the approval of the 2013 annual accounts, election of the board, and remuneration. This clearly indicates it is a formal notice sent to shareholders regarding an upcoming Annual General Meeting (AGM). The definition for AGM Information (AGM-R) covers presentations and materials shared during the AGM, and an official notice calling for the meeting falls under this category as preparatory material for the event. It is not the full Annual Report (10-K) or a Proxy Statement (PSI), but specifically the meeting notice itself.
2014-04-22 English
PCI Biotech: Innkalling til ordinær generalforsamling 2014
Audit Report / Information Classification · 98% confidence The document is titled "Årsrapport 2013" (Annual Report 2013) and contains extensive sections detailing the company's activities, technology (PCI), clinical trial progress (Phase I/II studies for head/neck cancer and cholangiocarcinoma), R&D projects (vaccines, macromolecules), organizational structure, and financial context (though detailed financials might be elsewhere, the structure is typical of an annual report). The length (over 129,000 characters) confirms it is a comprehensive document, not a brief announcement. The presence of 'Årsberetning' (Annual Report) strongly indicates this classification. Although the Norwegian term 'Årsrapport' is used, it directly corresponds to the definition of an Annual Report (10-K equivalent for non-US filers, or a comprehensive annual review). FY 2013
2014-04-22 Norwegian
PCI Biotech: Notice of Annual General Meeting 2014
Remuneration Information Classification · 99% confidence The document title is "Styrets erklæring om fastsettelse av lønn og annen godtgjørelse for ledende ansatte" (Board's statement on determination of salary and other remuneration for executive employees). The text explicitly states it is prepared by the board in accordance with Norwegian public limited liability companies act (§ 6-16a) and presented to the general meeting (§ 5-6 third paragraph). This content directly addresses executive compensation, bonuses, stock options, and pension schemes, which falls under the definition of remuneration information for directors and top executives. This aligns perfectly with the 'Remuneration Information' category, coded as DEF 14A, even though the document is Norwegian and not a US SEC DEF 14A filing, the *content* matches the definition provided for DEF 14A (Report detailing compensation for top executives and directors).
2014-04-22 English
PCI Biotech: Innkalling til ordinær generalforsamling 2014
Remuneration Information Classification · 99% confidence The document text is a preliminary recommendation ('Foreløpig innstilling') from the Nomination Committee ('Valgkomitéen') of PCI Biotech Holding ASA regarding the re-election of board members and compensation for the board and the committee itself. This content directly relates to the composition of the board and governance structure, which falls under Board/Management Information (MANG) or Governance Information (CGR). Since it specifically deals with nominations for the board of directors, MANG is the most precise fit, as it covers 'Announcement of changes in the company's board of directors or senior management.' The document is short (1418 chars) and announces the committee's findings and upcoming final decision, making it an announcement about management/board composition.
2014-04-22 Norwegian
PCI Biotech: Notice of Annual General Meeting 2014
Board/Management Information Classification · 95% confidence The document text is a preliminary recommendation ('Foreløpig innstilling') from the Nomination Committee ('Valgkomitéen') of PCI Biotech Holding ASA regarding the re-election of board members and compensation for the board and the committee itself. This content directly relates to the composition of the board and governance structure, which falls under Board/Management Information (MANG) or Governance Information (CGR). Since it specifically deals with nominations for the board of directors, MANG is the most precise fit, as it covers 'Announcement of changes in the company's board of directors or senior management.' The document is short (1418 chars) and announces the committee's findings and upcoming final decision, making it an announcement about management/board composition.
2014-04-22 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.